Multimorbidity Among Patients Receiving Home Care in Japan: Prevalence, Levels, and Association With Emergency Home Visits
Background: Despite its clinical importance in primary care, the prevalence and levels of multimorbidity among patients receiving home-based medical care remain poorly characterized, and its potential impact on emergency home visits is unclear. This study described the prevalence and levels of multimorbidity among patients receiving physician-led home care in Japan and examined the association between multimorbidity level and emergency home visits. Methods: A multicenter cross-sectional study was conducted in 2024 using physician-completed questionnaires derived from medical records. Multimorbidity was defined as the presence of two or more chronic conditions. Based on prior literature, multimorbidity level was categorized as low (2-3 conditions), medium (4-5 conditions), or high (≥ 6 conditions). The primary outcome was the occurrence of an emergency home visit within the preceding month. Results: Among 506 included patients, 94.7% met criteria for multimorbidity, and 13.2% required an emergency home visit. In multivariable generalized linear mixed-effects models with a logit link, higher multimorbidity levels were independently associated with increased odds of emergency home visits, with adjusted odds ratios of 2.16 (95% CI, 1.09-4.31) for the medium-level group and 2.72 (95% CI, 1.19-6.19) for the high-level group compared with the low-level group. Conclusions: Multimorbidity was highly prevalent among Japanese patients receiving home care, exceeding prior domestic estimates while aligning with international reports. Higher levels of multimorbidity were associated with an increased likelihood of emergency home visits, suggesting that assessment of multimorbidity level may, if confirmed in future studies, inform risk stratification and policy planning for home-based care services. Trial Registration: UMIN000056282.
Authors
- Shuhei Hamada (ORCID: https://orcid.org/0000-0001-6440-9612)
- Gen Nakayama (ORCID: https://orcid.org/0000-0003-2578-5732)
- Natsuki Kajikawa (ORCID: https://orcid.org/0000-0001-7220-7738)
- Jun Hamano (ORCID: https://orcid.org/0000-0003-0304-9881)
- Mitsuaki Ishii (ORCID: https://orcid.org/0000-0002-9535-1932)
- Shoichi Masumoto (ORCID: https://orcid.org/0000-0002-7433-1625)
- Takashi Inaba (ORCID: https://orcid.org/0000-0002-0598-4120)
- Yu Sun (ORCID: https://orcid.org/0000-0002-3784-4333)
- Noriyuki Kimura
- Sayaka Nin (ORCID: https://orcid.org/0009-0008-5243-3365)
Institutions
- Hokkaido University of Science (JP)
- University of Tsukuba (JP)
- Keio University (JP)
- Hokkaido Pharmaceutical University (JP)
- Tsukuba Medical Center Hospital (JP)
- Pfizer (Japan) (JP)
- Saiseikai Ibaraki Hospital (JP)
Publication Details
- Journal
- Journal of General and Family Medicine
- Published
- 2026-08-25
- DOI
- https://doi.org/10.1002/jgf2.70170
- Primary Topic
- Chronic Disease Management Strategies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Japan Society for the Promotion of Science